carmustine has been researched along with Meningeal Neoplasms in 17 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
Meningeal Neoplasms: Benign and malignant neoplastic processes that arise from or secondarily involve the meningeal coverings of the brain and spinal cord.
| Excerpt | Relevance | Reference |
|---|---|---|
| "At this time, methotrexate and CNS radiotherapy used together offer the best chance for prolonged remissions in children who develop overt CNS leukemia." | 4.76 | Treatment of overt CNS leukemia. ( Filler, J; Humphrey, GB; Krous, HF; Maxwell, JD; VanHoutte, JJ, 1979) |
| " Two doses of carmustine at intervals of one week could eradicate the disease even during the phase of logarithmic growth of the leukaemic cells, this result depending upon the level of treatment and time of dosing post-inoculation with leukaemic cells." | 1.27 | Testicular invasion and relapse and meningeal involvement in a rat T-cell leukaemia. ( Bock, M; Jackson, H; Jackson, NC; Lendon, M, 1984) |
| "Four cases of breast cancer with meningeal involvement are presented and a review of the literature is given." | 1.26 | [(Meningeal carcinomatosis in patients with breast cancer)]. ( Freund, M; Ostendorf, P; Waller, HD, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (76.47) | 18.7374 |
| 1990's | 2 (11.76) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (11.76) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Autran, D | 1 |
| Barrie, M | 1 |
| Matta, M | 1 |
| Monserrat, C | 1 |
| Campello, C | 1 |
| Petrirena, G | 1 |
| Boucard, C | 1 |
| Padovani, L | 1 |
| Loundou, A | 1 |
| Appay, R | 1 |
| Graillon, T | 1 |
| Dufour, H | 1 |
| Figarella-Branger, D | 1 |
| Chinot, O | 1 |
| Tabouret, E | 1 |
| Huang, HC | 1 |
| Cheng, AL | 1 |
| Lin, CW | 1 |
| Kuo, SH | 1 |
| Yoshida, T | 2 |
| Ushio, Y | 3 |
| Hayakawa, T | 2 |
| Shimizu, K | 2 |
| Mogami, H | 2 |
| Nakata, Y | 2 |
| Sakamoto, Y | 2 |
| Robustelli della Cuna, G | 1 |
| Paoletti, P | 1 |
| Bernardo, G | 1 |
| Knerich, R | 1 |
| Butti, G | 1 |
| Cuzzoni, Q | 1 |
| Vincent, FM | 1 |
| Jackson, H | 1 |
| Jackson, NC | 1 |
| Bock, M | 1 |
| Lendon, M | 1 |
| Nemoto, S | 1 |
| Kitamura, I | 1 |
| Kochi, M | 1 |
| Matsumoto, Y | 1 |
| Ueoka, R | 1 |
| Kuratsu, J | 1 |
| Humphrey, GB | 1 |
| Krous, HF | 1 |
| Filler, J | 1 |
| Maxwell, JD | 1 |
| VanHoutte, JJ | 1 |
| Freund, M | 1 |
| Ostendorf, P | 1 |
| Waller, HD | 1 |
| Kornblith, PL | 1 |
| Szypko, PE | 1 |
| Sayas, MJ | 1 |
| Sanz, MA | 1 |
| Martín-Aragonés, G | 1 |
| Javier Rafecas, F | 1 |
| Martínez, JA | 1 |
| Lorenzo, IJ | 1 |
| Sanz, GF | 1 |
| Gomis, F | 1 |
| Marty, ML | 1 |
| Donadio, D | 1 |
| Navarro, M | 1 |
| Izarn, P | 1 |
| Constine, LS | 1 |
| Rubin, P | 1 |
| Woolf, PD | 1 |
| Doane, K | 1 |
| Lush, CM | 1 |
| Sullivan, MP | 1 |
| Boyett, J | 1 |
| Pullen, J | 1 |
| Crist, W | 1 |
| Doering, EJ | 1 |
| Trueworthy, R | 1 |
| Hvizdala, E | 1 |
| Ruymann, F | 1 |
| Steuber, CP | 1 |
| Panasci, LC | 1 |
| Dufour, M | 1 |
| Chevalier, L | 1 |
| Isabel, G | 1 |
| Lazarus, P | 1 |
| McQuillan, A | 1 |
| Arbit, E | 1 |
| Brem, S | 1 |
| Feindel, W | 1 |
1 review available for carmustine and Meningeal Neoplasms
| Article | Year |
|---|---|
Treatment of overt CNS leukemia.
Topics: Adrenal Cortex Hormones; Aminopterin; Antineoplastic Agents; Asparaginase; Blood-Brain Barrier; Carm | 1979 |
1 trial available for carmustine and Meningeal Neoplasms
| Article | Year |
|---|---|
Pediatric Oncology Group experience with modified LSA2-L2 therapy in 107 children with non-Hodgkin's lymphoma (Burkitt's lymphoma excluded).
Topics: Adolescent; Antineoplastic Agents; Asparaginase; Bone Marrow; Carmustine; Child; Child, Preschool; C | 1985 |
15 other studies available for carmustine and Meningeal Neoplasms
| Article | Year |
|---|---|
Leptomeningeal Gliomatosis: A Single Institution Study of 31 Patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Combined M | 2019 |
Primary central nervous system diffuse large B cell lymphoma transformed from orbital mucosa-associated lymphoid tissue lymphoma: complete response to combined intrathecal and systemic rituximab.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carmu | 2013 |
[Chemotherapy of experimental meningeal gliomatosis].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain; Carmustine; Glioma; Male; | 1984 |
Clinical toxicity of combined modality treatment with nitrosourea derivatives for central nervous system tumors.
Topics: Bone Marrow Diseases; Brain Neoplasms; Carmustine; Gastrointestinal Diseases; Glioblastoma; Glioma; | 1982 |
Spinal leptomeningeal invasion from intracranial glioblastoma multiforme.
Topics: Brain Neoplasms; Carmustine; Cauda Equina; Cerebrospinal Fluid; Child, Preschool; Cobalt Radioisotop | 1983 |
Testicular invasion and relapse and meningeal involvement in a rat T-cell leukaemia.
Topics: Animals; Carmustine; Disease Models, Animal; Female; Leukemia, Lymphoid; Male; Meningeal Neoplasms; | 1984 |
[Meningeal gliomatosis models as a chemosensitivity assay system].
Topics: Animals; Antineoplastic Agents; Carmustine; Cell Division; Cell Survival; Disease Models, Animal; Dr | 1984 |
[Intravascular surgery for brain tumors].
Topics: Brain Neoplasms; Carmustine; Chemoembolization, Therapeutic; Humans; Meningeal Neoplasms; Meningioma | 1993 |
Intrathecal chemotherapy with 1,3-bis(2-chloroethyl)-1-nitrosourea encapsulated into hybrid liposomes for meningeal gliomatosis: an experimental study.
Topics: Animals; Antineoplastic Agents, Alkylating; Carmustine; Cell Division; Dogs; Drug Carriers; Glioma; | 1996 |
[(Meningeal carcinomatosis in patients with breast cancer)].
Topics: Adult; Aged; Breast Neoplasms; Carmustine; Female; Humans; Injections, Spinal; Mastectomy; Meningeal | 1979 |
Variations in response of human brain tumors to BCNU in vitro.
Topics: Brain Neoplasms; Carmustine; Cells, Cultured; Glioma; Humans; Meningeal Neoplasms; Meningioma | 1978 |
[Treatment of acute adult myeloblastic leukemia with intensive chemotherapy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Carmustine; Combined Modality Thera | 1986 |
[Neuromeningeal localizations in acute leukemia and non-Hodgkin's lymphoma. Protocol combining BCNU-cytosine arabinoside].
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Cytarabi | 1987 |
Hyperprolactinemia and hypothyroidism following cytotoxic therapy for central nervous system malignancies.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Carmustine; Cerebellar Neoplasms; Child; Child, Preschool; | 1987 |
Utilization of the HTSCA and CFU-C assay to identify two new 2-chloroethylnitrosourea congeners of amino acid amides with increased in vitro activity against human glioma compared with BCNU.
Topics: Antineoplastic Agents; Bone Marrow; Carmustine; Colony-Forming Units Assay; Glioma; Humans; In Vitro | 1985 |